DMedical (ASX:4DX) has climbed to a lofty valuation just short of $4.80 on Wednesday morning, bringing the biotech darling to a market cap above A$2.5 billion; posting 1Y returns of +780% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback